Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes.

Counterregulatory hormone responses to hypoglycemia were examined in six healthy controls and in six patients with type I diabetes before and after 4 to 8 months of insulin pump treatment. The insulin clamp technique was used to provide an identical hypoglycemic stimulus (about 50 mg/dL) in each study group. Before pump treatment, the release of counterregulatory hormones (except glucagon) during the hypoglycemic period was not significantly different in diabetics from that in normal controls. However, when values before and after pump treatment in diabetics were compared, there were significant reductions in epinephrine (304 +/- 70 and 127 +/- 43 pg/mL; p less than 0.01), growth hormone (45 +/- 12 and 18 +/- 5 ng/mL; p less than 0.05), and cortisol (20 +/- 3 and 10 +/- 2 micrograms/dL; p less than 0.01) levels during hypoglycemia. Defective glucagon release during hypoglycemia in the diabetics was not corrected by pump treatment. Intensive insulin treatment of patients with type I diabetes causes a generalized reduction in counterregulatory hormone release after a moderate fall in blood glucose levels. This reduction may impair glucose counterregulation and diminish perception of hypoglycemia, thereby increasing the risk of hypoglycemic episodes.

[1]  A H Clemens,et al.  Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. , 1980, The New England journal of medicine.

[2]  S. Fajans,et al.  Fasting hypoglycemia in adults. , 1976, The New England journal of medicine.

[3]  R. Rizza,et al.  Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. , 1979, The Journal of clinical investigation.

[4]  R. Unger.  Special Comment: Meticulous Control of Diabetes: Benefits, Risks, and Precautions , 1982, Diabetes.

[5]  J. Gerich,et al.  Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.

[6]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[7]  R. Sherwin,et al.  Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. , 1979, The Journal of clinical investigation.

[8]  W. Tamborlane,et al.  Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. , 1980, The American journal of medicine.

[9]  N Eigler,et al.  Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. , 1979, The Journal of clinical investigation.

[10]  T. Merimee,et al.  Stabilization of plasma glucose during fasting; Normal variations in two separate studies. , 1974, The New England journal of medicine.

[11]  U. Smith,et al.  Importance of Glucose Control for the Recovery from Hypoglycemia in Insulin-dependent Diabetics , 1982, Diabetes.

[12]  J. Tobin,et al.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man. , 1976, Journal of applied physiology.

[13]  P. Cryer,et al.  Plasma catecholamines in diabetes. The syndromes of hypoadrenergic and hyperadrenergic postural hypotension. , 1978, The American journal of medicine.

[14]  R. Unger,et al.  Pancreatic glucagon secretion in normal and diabetic subjects. , 1969, The American journal of the medical sciences.

[15]  P. Cryer,et al.  The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. , 1976, The Journal of clinical investigation.

[16]  P. Brunetti,et al.  Effects of Long-Term Optimization and Short-Term Deterioration of Glycemic Control on Glucose Counterregulation in Type I Diabetes Mellitus , 1984, Diabetes.

[17]  R. Hoeldtke,et al.  Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. , 1982, Annals of internal medicine.

[18]  P. Cryer,et al.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. , 1983, The New England journal of medicine.

[19]  P. Brunetti,et al.  The Adrenergic Contribution to Glucose Counterregulation in Type I Diabetes Mellitus: Dependency on A-Cell Function and Mediation Through Beta2-Adrenergic Receptors , 1983, Diabetes.

[20]  P. Cryer,et al.  Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. , 1979, The American journal of physiology.

[21]  K. Polonsky,et al.  Lack of Glucagon Response to Hypoglycemia in Type I Diabetics After Long-Term Optimal Therapy with a Continuous Subcutaneous Insulin Infusion Pump , 1983, Diabetes.

[22]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[23]  P. Cryer,et al.  Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. , 1980, The Journal of clinical endocrinology and metabolism.

[24]  P. D. de Moor,et al.  Fluorimetric determination of free plasma 11-hydroxycorticosteroids in man. , 1960, Acta endocrinologica.

[25]  P. Brunetti,et al.  Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion , 1983, Diabetes.

[26]  S. Berson,et al.  Separation of Antibody-Bound and Unbound Peptide Hormones Labelled with Iodine-131 by Talcum Powder and Precipitated Silica , 1966, Nature.

[27]  D. Johnson,et al.  Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man. , 1977, The Journal of clinical endocrinology and metabolism.

[28]  R. DeFronzo,et al.  Stimulation of Counterregulatory Hormonal Responses in Diabetic Man by a Fall in Glucose Concentration , 1980, Diabetes.

[29]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[30]  R. Rizza,et al.  Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. , 1980, Metabolism: clinical and experimental.

[31]  P. Felig,et al.  Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. , 1974, The Journal of clinical investigation.

[32]  J. Avruch,et al.  Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study. , 1982, Annals of internal medicine.

[33]  L. Rigg,et al.  Hypoglycemic Coma Associated with Subcutaneous Insulin Infusion by Portable Pump , 1981, Diabetes Care.

[34]  P. Cryer.  Glucose Counterregulation in Man , 1981, Diabetes.

[35]  P. Brunetti,et al.  Important Role of Adrenergic Mechanisms in Acute Glucose Counterregulation Following Insulin-induced Hypoglycemia in Type I Diabetes: Evidence for an Effect Mediated by Beta-Adrenoreceptors , 1982, Diabetes.

[36]  J. Wahren.  Glucose Turnover During Exercise in Healthy Man and in Patients with Diabetes Mellitus , 1979, Diabetes.

[37]  P. Cryer,et al.  Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. , 1984, The New England journal of medicine.

[38]  H. Keen,et al.  LONG-TERM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN DIABETICS AT HOME , 1979, The Lancet.

[39]  R. Sherwin,et al.  Altered Responsiveness to Cortisol, Epinephrine, and Glucagon in Insulin-infused Juvenile-onset Diabetics: A Mechanism for Diabetic Instability , 1980, Diabetes.

[40]  H. Shamoon,et al.  Impaired Counterregulation of Hypoglycemia in Insulin-dependent Diabetes Mellitus , 1983, Diabetes.

[41]  P. Felig,et al.  Intensive ambulatory treatment of insulin-dependent diabetes. , 1982, Annals of internal medicine.